Cost-effectiveness analysis of protease inhibitor monotherapy vs. ongoing triple-therapy in the long-term management of HIV patients

Lars Oddershede, Simon Walker, Nicholas Paton, Wolfgang Stöhr, David Dunn, Mark Sculpher

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

    OriginalsprogEngelsk
    ArtikelnummerA683
    TidsskriftValue in Health
    Vol/bind17
    Udgave nummer7
    ISSN1098-3015
    DOI
    StatusUdgivet - 12 nov. 2014
    BegivenhedInternational Society for Pharmacoeconomics and Outcomes Research 17th Annual European Congress - The Amsterdam RAI , Amsterdam, Holland
    Varighed: 8 nov. 201412 nov. 2014
    Konferencens nummer: 17

    Konference

    KonferenceInternational Society for Pharmacoeconomics and Outcomes Research 17th Annual European Congress
    Nummer17
    LokationThe Amsterdam RAI
    Land/OmrådeHolland
    ByAmsterdam
    Periode08/11/201412/11/2014

    Emneord

    • HIV
    • HAART
    • Protease Inhibitor
    • Drug Costs
    • University of York

      Lars Oddershede (Gæsteforsker)

      30 okt. 201329 mar. 2014

      Aktivitet: Gæsteophold ved andre institutioner

    Citationsformater